Restoration of erythropoiesis by rituximab in an adult patient with primary acquired pure red cell aplasia refractory to conventional treatment
Open Access
- 6 March 2002
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 116 (3) , 727-728
- https://doi.org/10.1046/j.1365-2141.2002.3317_3.x
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemiaBlood, 2001
- Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.Journal of Clinical Oncology, 1998
- The pathophysiology of pure red cell aplasia: implications for therapyBlood, 1996